お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
972332

空間的ゲノミクスおよびトランスクリプトミクスの世界市場 (2020-2030年):製品タイプ・検体タイプ・ワークフロー・用途・エンドユーザー・地域別

Global Spatial Genomics and Transcriptomics Market: Focus on Product Type, Sample Type, Workflow, Application, End User, Region and Competitive Landscape - Analysis and Forecast, 2020-2030

出版日: | 発行: BIS Research Inc. | ページ情報: 英文 160 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.84円
空間的ゲノミクスおよびトランスクリプトミクスの世界市場 (2020-2030年):製品タイプ・検体タイプ・ワークフロー・用途・エンドユーザー・地域別
出版日: 2020年11月20日
発行: BIS Research Inc.
ページ情報: 英文 160 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の空間的ゲノミクスおよびトランスクリプトミクスの市場規模は予測期間中23.20%のCAGRで推移し、2030年には21億7300万米ドルの規模に成長すると予測されています。癌、神経障害、希少疾患など、各種遺伝性疾患の有病率の増加、高解像度の多重アッセイおよび機器の開発の促進、シーケンシング技術の技術的進歩、大規模なR&D投資など、さまざまな要因が同市場の成長を推進しています。

当レポートでは、世界の空間的ゲノミクスおよびトランスクリプトミクスの市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、検体タイプ・製品タイプ・ワークフロー・用途・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

エグゼクティブサマリー

第1章 製品の定義

第2章 調査手法

第3章 市場概要

  • 空間的生物学:次世代の組織研究技術
  • 空間オミクス技術に対するCOVID-19の影響

第4章 市場力学

  • 概要
  • 影響分析
  • 成長推進因子
  • 成長抑制因子
  • 市場機会
  • 空間的メタゲノミクスなどの新しい研究用途への拡張
  • 新興市場への拡大

第5章 競合情勢

  • 重要戦略・展開

第6章 市場分析・予測:検体タイプ別

  • 凍結新鮮組織
  • 凍結固定組織
  • ホルマリン固定パラフィン包埋 (FFPE) 組織
  • 培養細胞

第7章 市場分析・予測:製品タイプ別

  • キット・アッセイ
    • サンプル調製キット
    • サンプルエンリッチメントキット
  • 機器
    • スライドスキャナー
    • 顕微鏡検査
    • マスサイトメトリー
  • ソフトウェア
  • サービス

第8章 市場分析・予測:ワークフロー別

  • 空間的イメージング
    • レーザーキャプチャーマイクロダイセクション (LCM)
    • 免疫組織化学 (IHC)
    • 蛍光in situハイブリダイゼーション (FISH)
    • 顕微鏡検査
    • バーコード
    • その他
  • 空間的シーケンス
    • 次世代シーケンシング (NGS)
    • インビボ転写
    • 蛍光in situシーケンシング (FISSEQ)
    • ミクロトームシーケンス
    • その他
  • 空間的分析
    • データ視覚化ツール
    • データ分析ツール

第9章 市場分析・予測:用途別

  • 診断
    • 癌診断
    • 神経学診断
    • 免疫学診断
    • その他
  • トランスレーショナル研究
  • 創薬・開発
  • 単一細胞分析
  • 細胞生物学
  • その他

第10章 市場分析・予測:エンドユーザー別

  • 学術・研究機関
  • バイオ医薬品・バイオテクノロジー企業
  • 受託研究機関
  • その他

第11章 市場分析・予測:地域・主要国別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 中国
    • 日本
    • オーストラリア
    • インド
    • シンガポール
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • その他の地域

第12章 企業プロファイル

  • Fluidigm Corporation
  • 10x Genomics, Inc.
  • NanoString Technologies, Inc.
  • Bio-Techne Corporation
  • Flagship Biosciences, Inc.
  • Akoya Biosciences, Inc.
  • BioSpyder Technologies
  • S2 Genomics, Inc.
  • IONpath, Inc.
  • Miltenyi Biotec
  • RareCyte, Inc.
  • Visikol, Inc.
図表

List of Tables

  • Table 4.1: Likert Scale
  • Table 4.2: Impact Analysis of Market Drivers
  • Table 4.3: Impact Analysis of Market Restraints

List of Figures

  • Figure 1: Global Neurological Disorder Burden, 2020
  • Figure 2: Global Health Estimates 2030, Deaths by Age
  • Figure 3: Impact Analysis of Market Drivers and Market Challenges on the Global Spatial Genomics and Transcriptomics Market
  • Figure 4: Global Spatial Genomics and Transcriptomics Market (by Product Type), $Million, 2020 vs. 2030
  • Figure 5: Global Spatial Genomics and Transcriptomics Market (by Application), $Million , 2020 vs. 2030
  • Figure 6: Global Spatial Genomics and Transcriptomics Market (by Sample Type), $Million , 2020 vs. 2030
  • Figure 7: Global Spatial Genomics and Transcriptomics Market (by Workflow), $Million, 2020 vs. 2030
  • Figure 8: Global Spatial Genomics and Transcriptomics Market (by End User), $Million, 2020 vs. 2030
  • Figure 9: Global Spatial Genomics and Transcriptomics Market Snapshot
  • Figure 1.1: Global Spatial Genomics and Transcriptomics Market Segments
  • Figure 2.1: Primary Research Methodology
  • Figure 2.2: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 2.3: Top-Down Approach (Segment-Wise Analysis)
  • Figure 4.1: U.S. Prevalence of Lyme Disease 2009-2018:
  • Figure 4.2: Global Prevalence Rate of Selected Rare Diseases Per 100,000 People
  • Figure 4.3: Global Spatial Genomics and Transcriptomics Market (Service), 2020 and 2030
  • Figure 4.4: Global Spatial Genomics and Transcriptomics Market (FISSEQ), 2020 and 2030
  • Figure 5.1: Share of Key Developments and Strategies, 2017-2020
  • Figure 5.2: Product Launch and Upgradation Share (by Company), 2017-2020
  • Figure 5.3: Synergistic Activities Share (by Company), 2017-2020
  • Figure 5.4: Funding and Expansion Share (by Company), 2017-2020
  • Figure 5.5: Merger and Acquisition Share (by Company), 2017-2020
  • Figure 6.1: Global Spatial Genomics and Transcriptomics Market (by Sample Type), $Million, 2019-2030
  • Figure 6.2: Global Spatial Genomics and Transcriptomics Market (Fresh Frozen Tissues), $Million, 2019-2030
  • Figure 6.3: Global Spatial Genomics and Transcriptomics Market (Fixed Frozen Tissues), $Million, 2019-2030
  • Figure 6.4: Global Spatial Genomics and Transcriptomics Market (FFPE Tissues), $Million, 2019-2030
  • Figure 6.5: Global Spatial Genomics and Transcriptomics Market (Cultured cells), $Million, 2019-2030
  • Figure 7.1: Global Spatial Genomics and Transcriptomics Market (by Product Type), $Million, 2019-2030
  • Figure 7.2: Global Spatial Genomics and Transcriptomics Market (Kits and Assays), $Million, 2019-2030
  • Figure 7.3: Global Spatial Genomics and Transcriptomics Market (Sample Preparation Kits), $Million, 2019-2030
  • Figure 7.4: Global Spatial Genomics and Transcriptomics Market (Sample Enrichment Kits), $Million, 2019-2030
  • Figure 7.5: Global Spatial Genomics and Transcriptomics Market (Instrument), $Million, 2019-2030
  • Figure 7.6: Global Spatial Genomics and Transcriptomics Market (Slide Scanner), $Million, 2019-2030
  • Figure 7.7: Global Spatial Genomics and Transcriptomics Market (Microscopy), $Million, 2019-2030
  • Figure 7.8: Global Spatial Genomics and Transcriptomics Market (Mass Cytometry), $Million, 2019-2030
  • Figure 7.9: Global Spatial Genomics and Transcriptomics Market (Software), $Million, 2019-2030
  • Figure 7.10: Global Spatial Genomics and Transcriptomics Market (Services), $Million, 2019-2030
  • Figure 8.1: Global Spatial Genomics and Transcriptomics Market (by Workflow), $Million, 2019-2030
  • Figure 8.2: Global Spatial Genomics and Transcriptomics Market (Spatial Imaging), $Million, 2019-2030
  • Figure 8.3: Global Spatial Genomics and Transcriptomics Market (Laser Capture Microdissection), $Million, 2019-2030
  • Figure 8.4: Global Spatial Genomics and Transcriptomics Market (IHC), $Million, 2019-2030
  • Figure 8.5: Global Spatial Genomics and Transcriptomics Market ( FISH), $Million, 2019-2030
  • Figure 8.6: Global Spatial Genomics and Transcriptomics Market (Microscopy), $Million, 2019-2030
  • Figure 8.7: Global Spatial Genomics and Transcriptomics Market (Barcodes), $Million, 2019-2030
  • Figure 8.8: Global Spatial Genomics and Transcriptomics Market (Other), $Million, 2019-2030
  • Figure 8.9: Global Spatial Genomics and Transcriptomics Market (by Spatial Sequencing), $Million, 2019-2030
  • Figure 8.10: Global Spatial Genomics and Transcriptomics Market (NGS), $Million, 2019-2030
  • Figure 8.11: Global Spatial Genomics and Transcriptomics Market (In-Vivo Transcription), $Million, 2019-2030
  • Figure 8.12: Global Spatial Genomics and Transcriptomics Market (FISSEQ), $Million, 2019-2030
  • Figure 8.13: Global Spatial Genomics and Transcriptomics Market (Microtomy Sequencing), $Million, 2019-2030
  • Figure 8.14: Global Spatial Genomics and Transcriptomics Market (Other Sequencing), $Million, 2019-2030
  • Figure 8.15: Global Spatial Genomics and Transcriptomics Market (by Spatial Analysis), $Million, 2019-2030
  • Figure 8.16: Global Spatial Genomics and Transcriptomics Market (Data Visualization Tool), $Million, 2019-2030
  • Figure 8.17: Global Spatial Genomics and Transcriptomics Market (Data Analysis Tools), $Million, 2019-2030
  • Figure 9.1: Global Spatial Genomics and Transcriptomics Market (by Application), $Million, 2019-2030
  • Figure 9.2: Global Spatial Genomics and Transcriptomics Market (by Diagnostics), $Million, 2019-2030
  • Figure 9.3: Global Spatial Genomics and Transcriptomics Market (Cancer Diagnostics), $Million, 2019-2030
  • Figure 9.4: Global Spatial Genomics and Transcriptomics Market (Neurology Diagnostics), $Million, 2019-2030
  • Figure 9.5: Global Spatial Genomics and Transcriptomics Market (Immunology Diagnostics), $Million, 2019-2030
  • Figure 9.6: Global Spatial Genomics and Transcriptomics Market (Other Diagnostics), $Million, 2019-2030
  • Figure 9.7: Global Spatial Genomics and Transcriptomics Market (Translational Research), $Million, 2019-2030
  • Figure 9.8: Global Spatial Genomics and Transcriptomics Market (Drug Discovery and Development), $Million, 2019-2030
  • Figure 9.9: Global Spatial Genomics and Transcriptomics Market (Single Cell Analysis), $Million, 2019-2030
  • Figure 9.10: Global Spatial Genomics and Transcriptomics Market (Cell Biology), $Million, 2019-2030
  • Figure 9.11: Global Spatial Genomics and Transcriptomics Market (by Others), $Million, 2019-2030
  • Figure 10.1: Global Spatial Genomics and Transcriptomics Market (by End User), $Million, 2019-2030 $Million
  • Figure 10.2: Global Spatial Genomics and Transcriptomics Market (Academic and Research Institutions), $Million, 2019-2030
  • Figure 10.3: Global Spatial Genomics and Transcriptomics Market (Biopharmaceutical and Biotech Companies), $Million, 2019-2030
  • Figure 10.4: Global Spatial Genomics and Transcriptomics Market (Contract Research Organization), $Million, 2019-2030
  • Figure 10.5: Global Spatial Genomics and Transcriptomics Market (Other End User), $Million, 2019-2030
  • Figure 11.1: Global Spatial Genomics and Transcriptomics Market (by Region), $Million, 2020 and 2030
  • Figure 11.2: Global Spatial Genomics and Transcriptomics Market (by Region), $Million, 2019-2030
  • Figure 11.3: North America Spatial Genomics and Transcriptomics Market, $Million, 2019-2030
  • Figure 11.4: North America: Market Dynamics
  • Figure 11.5: North America Spatial Genomics and Transcriptomics Market (by Country), 2019-2030
  • Figure 11.6: U.S. Spatial Genomics and Transcriptomics Market, $Million, 2019-2030
  • Figure 11.7: Canada Spatial Genomics and Transcriptomics Market, $Million, 2019-2030
  • Figure 11.8: Europe Spatial Genomics and Transcriptomics Market, $Million, 2019-2030
  • Figure 11.9: Europe: Market Dynamics
  • Figure 11.10: Europe Spatial Genomics and Transcriptomics Market (by Country), $Million, 2019-2030
  • Figure 11.11: Germany Spatial Genomics and Transcriptomics Market, $Million, 2019-2030
  • Figure 11.12: France Spatial Genomics and Transcriptomics Market, $Million, 2019-2030
  • Figure 11.13: U.K. Spatial Genomics and Transcriptomics Market, $Million, 2019-2030
  • Figure 11.14: Italy Spatial Genomics and Transcriptomics Market, $Million, 2019-2030
  • Figure 11.15: Spain Spatial Genomics and Transcriptomics Market, $Million, 2019-2030
  • Figure 11.16: Rest-of-Europe Spatial Genomics and Transcriptomics Market, $Million, 2019-2030
  • Figure 11.17: Asia-Pacific Spatial Genomics and Transcriptomics Market, $Million, 2019-2030
  • Figure 11.18: APAC: Market Dynamics
  • Figure 11.19: APAC Spatial Genomics and Transcriptomics Market (by Country), $Million, 2019-2030
  • Figure 11.20: China Spatial Genomics and Transcriptomics Market, $Million, 2019-2030
  • Figure 11.21: Japan Spatial Genomics and Transcriptomics Market, $Million, 2019-2030
  • Figure 11.22: Australia Spatial Genomics and Transcriptomics Sequencing Market, $Million, 2019-2030
  • Figure 11.23: India Spatial Genomics and Transcriptomics Market, $Million, 2019-2030
  • Figure 11.24: Singapore Spatial Genomics and Transcriptomics Market, $Million, 2019-2030
  • Figure 11.25: RoAPAC Spatial Genomics and Transcriptomics Market, $Million, 2019-2030
  • Figure 11.26: Latin America Spatial Genomics and Transcriptomics Market, $Million, 2019-2030
  • Figure 11.27: Latin America: Market Dynamics
  • Figure 11.28: Latin America Spatial Genomics and Transcriptomics Market (by Country), 2019-2030
  • Figure 11.29: Brazil Spatial Genomics and Transcriptomics Market, $Million, 2019-2030
  • Figure 11.30: Mexico Spatial Genomics and Transcriptomics Market, $Million, 2019-2030
  • Figure 11.31: Rest-of-Latin America Spatial Genomics and Transcriptomics Market, $Million, 2019-2030
  • Figure 11.32: RoW Spatial Genomics and Transcriptomics Market, $Million, 2019-2030
  • Figure 12.1: Total Number of Companies Profiled
  • Figure 12.2: Fluidigm Corporation: Product Portfolio
  • Figure 12.3: Fluidigm Corporation: Overall Financials, 2017-2019
  • Figure 12.4: Fluidigm Corporation: Revenue (by Business Segment), 2017-2019
  • Figure 12.5: Fluidigm Corporation.: Revenue (by Region), 2017-2019
  • Figure 12.6: Fluidigm Corporation: R&D Expenditure, 2017-2019
  • Figure 12.7: Fluidigm Corporation: SWOT Analysis
  • Figure 12.8: 10x Genomics, Inc.: Product Portfolio
  • Figure 12.9: 10x Genomics, Inc.: Overall Financials, 2017-2019
  • Figure 12.10: 10x Genomics, Inc.: Revenue (by Business Segment), 2017-2019
  • Figure 12.11: 10x Genomics, Inc.: Revenue (by Region), 2017-2019
  • Figure 12.12: 10x Genomics, Inc.: R&D Expenditure, 2017-2019
  • Figure 12.13: 10x Genomics, Inc.: SWOT Analysis
  • Figure 12.14: NanoString Technologies, Inc.: Product Portfolio
  • Figure 12.15: NanoString Technologies, Inc.: Overall Financials, (2017-2019)
  • Figure 12.16: NanoString Technologies, Inc.: Revenue (by Business Segment), 2017-2019
  • Figure 12.17: NanoString Technologies, Inc.: Revenue (by Region), 2017-2019
  • Figure 12.18: NanoString Technologies, Inc.: R&D Expenditure, 2017-2019
  • Figure 12.19: NanoString Technologies, Inc.: SWOT Analysis
  • Figure 12.20: Bio-Techne Corporation: Product Portfolio
  • Figure 12.21: Bio-Techne Corporation: Overall Financials, 2018-2020
  • Figure 12.22: Bio-Techne Corporation: Revenue (by Business Segment), 2018-2020
  • Figure 12.23: Bio-Techne Corporation: Revenue (by Region), 2018-2020
  • Figure 12.24: Bio-Techne Corporation: R&D Expenditure, 2018-2020
  • Figure 12.25: Bio-Techne Corporation: SWOT Analysis
  • Figure 12.26: Flagship Biosciences, Inc.: Overall Product Portfolio
  • Figure 12.27: Flagship Biosciences, Inc.: SWOT Analysis
  • Figure 12.28: Akoya Biosciences, Inc.: Overall Product Portfolio
  • Figure 12.29: Akoya Biosciences, Inc.: SWOT Analysis
  • Figure 12.30: BioSpyder Technologies: Overall Product Portfolio
  • Figure 12.31: BioSpyder Technologies: SWOT Analysis
  • Figure 12.32: S2 Genomics, Inc.: Overall Product Portfolio
  • Figure 12.33: S2 Genomics, Inc.: SWOT Analysis
  • Figure 12.34: IONpath, Inc.: Overall Product Portfolio
  • Figure 12.35: IONpath, Inc.: SWOT Analysis
  • Figure 12.36: Miltenyi Biotec: Overall Product Portfolio
  • Figure 12.37: Miltenyi Biotec: SWOT Analysis
  • Figure 12.38: RareCyte, Inc.: Overall Product Portfolio
  • Figure 12.39: RareCyte, Inc.: SWOT Analysis
  • Figure 12.40: Visikol, Inc.: Overall Product Portfolio
  • Figure 12.41: Visikol, Inc.: SWOT Analysis
目次
Product Code: BHP1009SA

"Global Spatial Genomics and Transcriptomics Market to Reach $2,173.0 Million by 2030."

Market Report Coverage - Spatial Genomics and Transcriptomics

Market Segmentation

  • Product Type - Kits and Assays, Instruments, Software, and Services
  • Sample Type - Fresh Frozen Tissues, Fixed Frozen Tissues, Fixed-Formalin Paraffin Embedded Tissues, and Cultured Cells
  • Workflow - Spatial Imaging, Spatial Analysis, and Spatial Sequencing
  • Application - Diagnostics, Drug Discovery and Development, Translational Research, Single-Cell Analysis, Cell Biology and Others
  • End User - Academic and Research Institutions, Biopharmaceutical and Biotechnological Companies, Contract Research Organizations and Other End Users

Regional Segmentation

  • North America - U.S., Canada
  • Europe - Germany, France, Italy, U.K., Spain, and Rest-of-Europe
  • Asia-Pacific - China, Japan, India, Singapore, Australia, and Rest-of-Asia-Pacific (RoAPAC)
  • Latin America - Brazil, Mexico, and Rest-of-the-Latin America
  • Rest-of-the-World

Growth Drivers

  • Increasing Prevalence of Various Types of Genetic Disorders Globally
  • Technological Advancements in Sequencing Technologies
  • Increasing Research Funding in the Field of Spatial Transcriptomics

Market Challenges

  • High Capital Requirement Hampering the Expansion of Global Reach
  • Lack of Tools for Computational Analysis

Market Opportunities

  • Opportunity (by Product)
  • Opportunity (by Technology)
  • Expansion into New Research Application such as Spatial Metagenomics
  • Expansion into Emerging Markets

Key Companies Profiled

NanoString Technologies, Inc., S2 Genomics, Inc., Flagship Biosciences, Inc., Akoya Biosciences, Inc. RareCyte, Inc., IONpath, Inc., Fluidigm Corporation, 10x Genomics, Inc., Visikol, Inc., Miltenyi Biotec, and BioSpyder Technologies

Key Questions Answered in this Report:

  • What are the major market drivers, challenges, and opportunities in the global spatial genomics and transcriptomics market?
  • What is the potential impact of biotechnological advancement in the diagnostic industry among the end users, such as researchers, pathologists, and laboratory technicians?
  • What is the current market demand along with future expected demand for the global spatial genomics and transcriptomics market?
  • How have spatial profiling helped cellular imaging and visualization to become a prominent tool for diagnostics in various clinical applications?
  • What are the key development strategies which are implemented by the major players in order to sustain in the competitive market?
  • How is each segment of the market expected to grow during the forecast period from 2020 to 2030 based each on segment?

Following are each segment type:

  • product type
  • sample type
  • workflow
  • application
  • end user
  • region, namely, North America, Europe, Asia-Pacific, Rest-of-the-World (ROW)
  • Who are the leading players with significant offerings to the global spatial genomics and transcriptomics market? What is the expected market dominance for each of these leading players?
  • Which emerging companies are anticipated to be highly disruptive in the future, and what are their key strategies for sustainable growth in the global spatial genomics and transcriptomics market?

Market Overview

BIS Research healthcare experts have found the spatial genomics and transcriptomics market to be one of the most rapidly evolving markets, which is predicted to grow at a CAGR of 23.20% during the forecast period of 2020-2030. The market is driven by certain factors, which include the increasing prevalence of various types of genetic disorders, such as cancer, neurological disorder, and rare diseases, inciting the development of high-resolution multiplex assays and instruments, technological advancements in sequencing technologies, and significant research funding in the field of spatial-based technology for executing R&D exercises.

The market is favored by the development of spatial profiling-based solutions for visualization and analysis of tissue microenvironment, tumor biology, and tissue biomarker. The gradual increase in the prevalence of neurological disorders and rare diseases globally has furthered the spatial genomics and transcriptomics market.

Furthermore, several contract research organizations are focusing on the development of spatial profiling-based services, which enables simultaneous in-situ spatial analysis of multiple biomarkers proteins or more than a hundred mRNAs from single formalin-fixed paraffin-embedded (FFPE) tissue or frozen tissue section.

Within the research report, the market is segmented on the basis of product type, sample type, workflow, application, end users, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The exponential rise in the application of precision medicine on the global level has created a buzz among companies to invest in the development of high-resolution multiplex diagnostics providing information on cellular interaction and tissue heterogeneity to understand disease biology and pathology. Due to technologically advanced solutions and intense market penetration, BioTechne Corporation has been a pioneer in this field and has been a significant competitor in this market.

Other key players in the market are NanoString Technologies, Inc., S2 Genomics, Inc., Flagship Biosciences, Inc., Akoya Biosciences, Inc. RareCyte, Inc., IONpath, Inc., Fluidigm Corporation, 10x Genomics, Inc., Visikol, Inc., Miltenyi Biotec, and BioSpyder Technologies.

On the basis of region, North America holds the largest share of spatial genomics and transcriptomics market due to improved healthcare infrastructure, rise in per capita income, and availability of state-of-the-art research laboratories and institutions in the region. Apart from this, Europe region is anticipated to grow at the fastest CAGR of 23.54% during the forecast period 2020-2030.

The market utilizes several technologies, such as barcoding, sequencing, mass cytometry, and microscopy, for the development of instruments and assay for spatial profiling of tissue section to gain an understanding of tissue microenvironment. Each solution offered by the leading players is the combination of next-generation omics tools for application in several clinical areas, such oncology, neurology, immunology, and pathology.

Table of Contents

Executive Summary

1 Product Definition

  • 1.1 Inclusion and Exclusion
  • 1.2 Scope of Work
  • 1.3 Key Questions Answered in the Report

2 Research Methodology

  • 2.1 Primary Data Sources
  • 2.2 Secondary Data Sources
  • 2.3 Market Estimation Model
  • 2.4 Criteria for Company Profiling

3 Market Overview

  • 3.1 Spatial Biology: A Next-Generation Tissue Exploration Technology
  • 3.2 Impact of COVID-19 on Spatial Omics Technology

4 Market Dynamics

  • 4.1 Overview
  • 4.2 Impact Analysis
  • 4.3 Market Drivers
    • 4.3.1 Increasing Prevalence of Various Types of Genetic Disorders, Globally
    • 4.3.2 Technological Advancements in Sequencing Technologies
    • 4.3.3 Increasing Research Funding in the Field of Spatial Transcriptomics
  • 4.4 Market Restraints
    • 4.4.1 High Capital Requirement Hampering the Expansion of Global Reach
    • 4.4.2 Lack of Tools for Computational Analysis
  • 4.5 Market Opportunities
    • 4.5.1 Opportunity (by Product)
      • 4.5.1.1 Services
    • 4.5.2 Opportunity (by Technology)
      • 4.5.2.1 FISSEQ
  • 4.6 Expansion into New Research Application such as Spatial Metagenomics
  • 4.7 Expansion into Emerging Markets

5 Competitive Landscape

  • 5.1 Key Strategies and Development
    • 5.1.1 Product Launch and Upgradations
    • 5.1.2 Synergistic Activities
    • 5.1.3 Funding and Expansion
    • 5.1.4 Mergers and Acquisitions

6 Global Spatial Genomics and Transcriptomics Market (by Sample Type)

  • 6.1 Fresh Frozen Tissues
  • 6.2 Fixed Frozen Tissues
  • 6.3 Formalin Fixed Paraffin Embedded (FFPE) tissues
  • 6.4 Cultured Cells

7 Global Spatial Genomics and Transcriptomics Market (by Product Type)

  • 7.1 Kits and Assays
    • 7.1.1 Sample Preparation Kits
    • 7.1.2 Sample Enrichment Kits
  • 7.2 Instrument
    • 7.2.1 Slide Scanner
    • 7.2.2 Microscopy
    • 7.2.3 Mass Cytometry
  • 7.3 Software
  • 7.4 Services

8 Global Spatial Genomics and Transcriptomics Market (by Workflow)

  • 8.1 Spatial Imaging
    • 8.1.1 Laser Capture Microdissection (LCM)
    • 8.1.2 Immunohistochemistry (IHC)
    • 8.1.3 Fluorescent In-Situ Hybridization (FISH)
    • 8.1.4 Microscopy
    • 8.1.5 Barcodes
    • 8.1.6 Other
  • 8.2 Spatial Sequencing
    • 8.2.1 Next-Generation Sequencing (NGS)
    • 8.2.2 In-Vivo Transcription
    • 8.2.3 Fluorescent In-Situ Sequencing (FISSEQ)
    • 8.2.4 Microtomy Sequencing
    • 8.2.5 Other
  • 8.3 Spatial Analysis
    • 8.3.1 Data Visualization Tools
    • 8.3.2 Data Analysis Tools

9 Global Spatial Genomics and Transcriptomics Market (by Application)

  • 9.1 Diagnostics
    • 9.1.1 Cancer Diagnostics
    • 9.1.2 Neurology Diagnostics
    • 9.1.3 Immunology Diagnostics
    • 9.1.4 Other Diagnostics
  • 9.2 Translation Research
  • 9.3 Drug Discovery and Development
  • 9.4 Single Cell Analysis
  • 9.5 Cell Biology
  • 9.6 Other

10 Global Spatial Genomics and Transcriptomics Market (by End User)

  • 10.1 Academic and Research Institutions
  • 10.2 Biopharmaceutical and Biotechnological Companies
  • 10.3 Contract Research Organization
  • 10.4 Other End Users

11 Global Spatial Genomics and Transcriptomics Market (by Region)

  • 11.1 Overview
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 France
    • 11.3.3 U.K.
    • 11.3.4 Italy
    • 11.3.5 Spain
    • 11.3.6 Rest-of-Europe
  • 11.4 Asia-Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 Australia
    • 11.4.4 India
    • 11.4.5 Singapore
    • 11.4.6 Rest-of-APAC
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Rest-of-Latin America
  • 11.6 Rest-of-the-World

12 Company Profiles

  • 12.1 Fluidigm Corporation
    • 12.1.1 Company Overview
    • 12.1.2 Role of Fluidigm Corporation in Global Spatial Genomics and Transcriptomics Market
    • 12.1.3 Financials
    • 12.1.4 Key Insights About Financial Health of the Company
    • 12.1.5 SWOT Analysis
  • 12.2 10x Genomics, Inc.
    • 12.2.1 Company Overview
    • 12.2.2 Role of 10x Genomics, Inc. in Global Spatial Genomics and Transcriptomics Market
    • 12.2.3 Financials
    • 12.2.4 Key Insights About Financial Health of the Company
    • 12.2.5 SWOT Analysis
  • 12.3 NanoString Technologies, Inc.
    • 12.3.1 Company Overview
    • 12.3.2 Role of NanoString Technologies, Inc. in Global Spatial Genomics and Transcriptomics Market
    • 12.3.3 Key Insights About Financial Health of the Company
    • 12.3.4 SWOT Analysis
  • 12.4 Bio-Techne Corporation
    • 12.4.1 Company Overview
    • 12.4.2 Role of Bio-Techne Corporation in Global Spatial Genomics and Transcriptomics Market
    • 12.4.3 Key Insights About Financial Health of the Company
    • 12.4.4 SWOT Analysis
  • 12.5 Flagship Biosciences, Inc.
    • 12.5.1 Company Overview
    • 12.5.2 Role of Flagship Biosciences, Inc. in Global Spatial Genomics and Transcriptomics Market
    • 12.5.3 SWOT Analysis
  • 12.6 Akoya Biosciences, Inc.
    • 12.6.1 Company Overview
    • 12.6.2 Role of Akoya Biosciences, Inc. in Global Spatial Genomics and Transcriptomics Market
    • 12.6.3 SWOT Analysis
  • 12.7 BioSpyder Technologies
    • 12.7.1 Company Overview
    • 12.7.2 Role of BioSpyder Technologies in Global Spatial Genomics and Transcriptomics Market
    • 12.7.3 SWOT Analysis
  • 12.8 S2 Genomics, Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Role of S2 Genomics, Inc. in Global Spatial Genomics and Transcriptomics Market
    • 12.8.3 SWOT Analysis
  • 12.9 IONpath, Inc.
    • 12.9.1 Company Overview
    • 12.9.2 Role of IONpath, Inc. in Global Spatial Genomics and Transcriptomics Market
    • 12.9.3 SWOT Analysis
  • 12.1 Miltenyi Biotec
    • 12.10.1 Company Overview
    • 12.10.2 Role of Miltenyi Biotec in Global Spatial Genomics and Transcriptomics Market
    • 12.10.3 SWOT Analysis
  • 12.11 RareCyte, Inc.
    • 12.11.1 Company Overview
    • 12.11.2 Role of RareCyte, Inc. in Global Spatial Genomics and Transcriptomics Market
    • 12.11.3 SWOT Analysis
  • 12.12 Visikol, Inc.
    • 12.12.1 Company Overview
    • 12.12.2 Role of Visikol, Inc. in Global Spatial Genomics and Transcriptomics Market
    • 12.12.3 SWOT Analysis
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.